» Articles » PMID: 26890807

Association Between Multidisciplinary Team Care Approach and Survival Rates in Patients with Oral Cavity Squamous Cell Carcinoma

Overview
Journal Head Neck
Date 2016 Feb 19
PMID 26890807
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The purpose of this study was to investigate whether multidisciplinary team care (MDTC) is associated with outcomes in oral cavity squamous cell carcinoma (SCC).

Methods: We retrospectively examined 1616 patients with oral cavity SCC who underwent radical surgery between 1996 and 2011. The study participants were classified into 2 subgroups according to the use of MDTC.

Results: Five-year outcomes were significantly better in the MDTC group than in the no-MDTC group (neck control, 88% vs 84%, p = .0397; disease-specific survival [DSS], 83% vs 78%, p = .0114; and overall survival [OS], 70% vs 64%, p = .0002, respectively). Among patients who were scheduled to undergo adjuvant therapy, the number who completed their adjuvant treatment was significantly higher in the MDTC group than in the no-MDTC group (90% vs 60% to 70%, p < .001).

Conclusion: The association of MDTC with improved outcomes may be potentially explained by a better therapeutic alliance between the patient and the tumor board, and/or a greater thoroughness in clinical management. © 2016 Wiley Periodicals, Inc. Head Neck 38: E1544-E1553, 2016.

Citing Articles

Multidisciplinary tumor boards in oral cavity cancer: survival effect due to balancing guideline adherence and treatment delays.

Burkhardt V, El-Shabrawi K, Riemann S, Voss P, Becker C Front Oral Health. 2024; 5:1493319.

PMID: 39620063 PMC: 11604625. DOI: 10.3389/froh.2024.1493319.


Impact of Surgeon-Radiation Oncology Dyads in Oral Cavity Cancer Outcomes.

Wihlidal J, Esemezie A, Huang S, Watson E, Gilbert R, Waldron J Ann Surg Oncol. 2024; 32(2):1270-1279.

PMID: 39467971 DOI: 10.1245/s10434-024-16385-4.


Impact of Preoperative Multidisciplinary Conference on Head and Neck Reconstruction Outcomes.

Dang S, Hashimi B, Tang A, Kubik M, Solari M, Sridharan S Laryngoscope. 2024; 135(1):110-117.

PMID: 39077976 PMC: 11635136. DOI: 10.1002/lary.31665.


Pathogenesis and Therapy of Oral Carcinogenesis.

Tarle M, Luksic I Int J Mol Sci. 2024; 25(12).

PMID: 38928050 PMC: 11203620. DOI: 10.3390/ijms25126343.


Changes in multidisciplinary team decisions in a high volume head and neck oncological center following those made in its preferred partner.

Hendrickx J, Mennega T, Uppelschoten J, Leemans C Front Oncol. 2023; 13:1205224.

PMID: 37727212 PMC: 10505803. DOI: 10.3389/fonc.2023.1205224.